Semi-Annual Report (November 2020 – April 2021), WEISX Generated +7.74% on an Annualized Volatility of 7.06%
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
View Annual Report
ANNUAL REPORT MetLife, Inc. 2013 Chairman’s Letter To my fellow shareholders: When I became CEO in May of 2011, my mandate was clear: Improve the profitability and risk profile of the business. MetLife was the largest life insurer in the United States with a great brand and a nearly 145-year history of keeping its promises to policyholders, but we had taken on too much risk in certain parts of our business and our profitability was in the middle of the pack relative to industry peers. The first order of business for the executive group in 2011 was to develop a strategy to achieve our goal. It is not easy to turn a ship as large as MetLife, especially in an industry where profits emerge slowly over time. The strategy we launched in 2012 was not a one- or two-year strategy. It was a five-year strategy to raise our return on equity, reduce our cost of equity, and return capital to shareholders. Even though we have faced both economic and regulatory headwinds along the way, I am pleased to report that we are ahead of schedule on our plan to increase the profitability of MetLife’s business while also decreasing its level of risk. A Very Good Year Our progress was clearly evident in 2013. Operating earnings increased 11% over the prior year, exceeding our plan.1 Premiums, fees and other revenues increased 2% on a reported basis and 5% on a constant currency basis – solid top-line growth in light of our efforts to improve MetLife’s risk profile. -
Constructing an Alternative Allocation
DECEMBER 2018 Constructing an Alternative Allocation NOT FDIC INSURED | MAY LOSE VALUE | NO BANK GUARANTEE The opinions referenced are as of the date of the publication, are subject to change due to changes in the market or economic conditions, and may not necessarily come to pass. Information contained herein is for informational purposes only and should not be considered investment advice. Past performance is no guarantee of future results. CONSTRUCTING AN ALTERNATIVE ALLOCATION Important Information Some of the risks associated with investing in alternatives may include hedging risk – hedging activities can reduce investment performance through added costs; derivative risk – derivatives may experience greater price volatility than the underlying securities; short sale risk – investments may incur a loss without limit as a result of a short sale if the market value of the security increases; interest rate risk – loss of value for income securities as interest rates rise; credit risk – risk of the borrower to miss payments; liquidity risk – low trading volume may lead to increased volatility in certain securities; non-U.S. government obligation risk – non-U.S. government obligations may be subject to increased credit risk; portfolio selection risk – investment managers may select securities that fare worse than the overall market. Alternative investments may not be suitable for all investors. An investment in the Fund(s) is subject to risks, and you could lose money on your investment in the Fund(s). There can be no assurance that the Fund(s) will achieve its investment objective. Your investment in the Fund(s) is not a deposit in a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation (FDIC) or any other government agency. -
2009 FINANCIAL SUMMARY Enerplus Has a Plan and Is Transitioning Our Business from an Income Fund to a Competitive Growth and Income-Oriented Oil and Gas Company
Season in Review ENERPLUS RESOURCES 2009 FINANCIAL SUMMARY Enerplus has a plan and is transitioning our business from an income fund to a competitive growth and income-oriented oil and gas company. 1. Add more early-stage resource plays 2. Maintain a strong financial position 3. Focus our portfolio 4. Build our operational capability Enerplus is one of Canada’s oldest and largest independent oil and gas producers with a portfolio of both early-stage resource plays and mature cash-generating properties. We are focused on creating value for our investors through the successful development of our properties and the disciplined management of our balance sheet. Through these activities, we strive to provide investors with a competitive return comprised of both growth and income. 1 Financial and Operating Highlights 4 Management’s Discussion and Analysis 37 Financial Statements 67 Five-Year Detailed Statistical Review 68 Five-Year Operational Statistics 69 Supplemental Information 79 Abbreviations 80 Definitions 82 Board of Directors 83 Officers 84 Corporate Information 2009 SUMMARY Selected Financial and Operating Highlights Three months ended Twelve months ended December 31, December 31, SELECTED FINANCIAL RESULTS (in Canadian dollars) 2009 2008 2009 2008 Financial (000’s) Cash Flow from Operating Activities $ 188,579 $ 258,536 $ 775,786 $ 1,262,782 Cash Distributions to Unitholders(1) 95,550 167,017 368,201 786,138 Excess of Cash Flow Over Cash Distributions 93,029 91,519 407,585 476,644 Net Income 2,718 189,495 89,117 888,892 Debt Outstanding -
Eaton Vance Tax-Advantaged Bond and Option Strategies Fund Notice
Eaton Vance Tax-Advantaged Bond and Option Strategies Fund Notice of Changes to Fund Name, Investment Objective, Fees and Distributions The Board of Trustees of Eaton Vance Tax-Advantaged Bond and Option Strategies Fund (NYSE: EXD) (the “Fund”) has approved changes to the Fund’s name, investment objective and investment policies as described below. In connection with these changes, the portfolio managers of the Fund will change and the Fund’s investment advisory fee rate will be reduced. Each of the foregoing changes will be effective on or about February 8, 2019. Following implementation of the changes to the Fund’s investment objective and policies, the Fund will increase the frequency of its shareholder distributions from quarterly to monthly and raise the distribution rate as described below. Name. The Fund’s name will change to “Eaton Vance Tax-Managed Buy-Write Strategy Fund.” It will continue to be listed on the New York Stock Exchange under the ticker symbol “EXD.” Investment Objectives. As revised, the Fund will have a primary objective to provide current income and gains, with a secondary objective of capital appreciation. In pursuing its investment objectives, the Fund will evaluate returns on an after-tax basis, seeking to minimize and defer shareholder federal income taxes. There can be no assurance that the Fund will achieve its investment objectives. The Fund’s current investment objective is tax-advantaged income and gains. Principal Investment Policies. The Fund currently employs a tax-advantaged short-term bond strategy (“Bond Strategy”) and a rules-based option overlay strategy that consists of writing a series of put and call spreads on the S&P 500 Composite Stock Price Index® (the “S&P 500”) (“Option Overlay Strategy”). -
Confidential Treatment Requested by Lehman Brothers Holdings, Inc
CONFIDENTIAL TREATMENT REQUESTED BY LEHMAN BROTHERS HOLDINGS, INC. LBEX-WGM 747129 Content Pricing I. Organization 3 Organization Structure 4-5 Staffing 6 II. Pricing and Control Philosophy 7 Mark Review Process 8-9 Products with Fair Value Categories 10 Price Verification Thresholds 11 Complex Derivatives Transaction Review Committee 12-14 Model Approval Process and Control Committee 15-16 Ill. Summary ofPrice Verification Results 17 Executive Summary- Fixed Income Division 18 Price Verification Coverage - Fixed Income Division 19 Price Verification Projects- Fixed Income Division 20 Executive Summary- Equities Division 21-22 Price Verification Coverage - Equities Division 23 Price Verification Projects- Equities Division 24 lY. Examples of Price Verification 25 Interest Rate Products 26-30 Equities 31-34 Credit Products 35-44 V. Appendix 45 Explanation of Significant Variances -Fixed Income Division 46-48 r Explanation of Significant Variances - Equities Division 49-50 OJm ~ ~ G) :s;: -..J 2 ~ LEHMAN BROTHERS -..J ...... (...) CONFIDENTIAL TREATMENT REQUESTED BY 0 LEHMAN BROTHERS HOLDINGS, INC. c: ........,0 ca N CONFIDENTIAL TREATMENT REQUESTED BY LEHMAN BROTHERS HOLDINGS, INC. LBEX-WGM 747131 Organization Structure Pricing I Capital Markets Finance is a group offinance professionals who are independent from the business and report to the CFO ofthe firm. The group is closely aligned with the business units in order to enhance the control process and maximize the flow of communication across the organization. Capital Markets Finance is primarily accountable to: .. Protect the Firm .. Provide daily revenue analysis and reporting .. Provide an independent and documented validation of inventory valuations "' Ensure appropriateness of valuation adjustments that adhere to globally consistent and approved standards ., Ensure, in conjunction with Risk Management, that appropriate models are used to value derivative transactions . -
Shoppes of Middle Tennessee MURFREESBORO , TN
Shoppes of Middle Tennessee MURFREESBORO , TN OFFERING MEMORANDUM Shoppes of Middle Tennessee MURFREESBORO , TN CONFIDENTIALITY AND DISCLAIMER The information contained in the following Marketing Brochure is proprietary and strictly confidential. It is intended to be reviewed only by the party receiving it from Marcus & Millichap and should not be made available to any other person or entity without the written consent of Marcus & Millichap. This Marketing Brochure has been prepared to provide summary, unverified information to prospective purchasers, and to establish only a preliminary level of interest in the subject property. The information contained herein is not a substitute for a thorough due diligence investigation. Marcus & Millichap has not made any investigation, and makes no warranty or representation, with respect to the income or expenses for the subject property, the future projected financial performance of the property, the size and square footage of the property and improvements, the presence or absence of contaminating substances, PCB's or asbestos, the compliance with State and Federal regulations, the physical condition of the improvements thereon, or the financial condition or business prospects of any tenant, or any tenant’s plans or intentions to continue its occupancy of the subject property. The information contained in this Marketing Brochure has been obtained from sources we believe to be reliable; however, Marcus & Millichap has not verified, and will not verify, any of the information contained herein, nor has Marcus & Millichap conducted any investigation regarding these matters and makes no warranty or representation whatsoever regarding the accuracy or completeness of the information provided. All potential buyers must take appropriate measures to verify all of the information set forth herein. -
The Securities and Exchange Commission Has Not Necessarily Reviewed the Information in This Filing and Has Not Determined If It Is Accurate and Complete
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL Washington, D.C. 20549 OMB Number: 3235-0006 FORM 13F Expires: July 31, 2015 Estimated average burden FORM 13F COVER PAGE hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 03-31-2019 Check here if Amendment Amendment Number: This Amendment (Check only one.): is a restatement. adds new holdings entries. Institutional Investment Manager Filing this Report: Name: AMALGAMATED BANK Address: 275 SEVENTH AVENUE 9TH FLOOR NEW YORK, NY 10001 Form 13F File 028-04148 Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: GREGORY W SPOCK VICE PRESIDENT - TRUST COMPLIANCE Title: OFFICER Phone: 212-895-4836 Signature, Place, and Date of Signing: GREGORY W SPOCK NEW YORK, NY 05-15-2019 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 13F COMBINATION REPORT. -
Oakworth Capital, Inc. Form 13F-HR Filed 2021-07-20
SECURITIES AND EXCHANGE COMMISSION FORM 13F-HR Initial quarterly Form 13F holdings report filed by institutional managers Filing Date: 2021-07-20 | Period of Report: 2021-06-30 SEC Accession No. 0001567619-21-013688 (HTML Version on secdatabase.com) FILER Oakworth Capital, Inc. Mailing Address Business Address 850 SHADES CREEK 850 SHADES CREEK CIK:1588871| IRS No.: 463019611 | State of Incorp.:AL | Fiscal Year End: 1231 PARKWAY PARKWAY Type: 13F-HR | Act: 34 | File No.: 028-15704 | Film No.: 211100272 BIRMINGHAM AL 35209 BIRMINGHAM AL 35209 205-263-4700 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE OMB Number: 3235-0006 COMMISSION Expires: July 31, 2015 Washington, D.C. 20549 Estimated average burden hours per response: 23.8 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 06-30-2021 Check here if Amendment: ☐ Amendment Number: This Amendment (Check only one.): ☐ is a restatement. ☐ adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Oakworth Capital, Inc. Address: 850 SHADES CREEK PARKWAY BIRMINGHAM, AL 35209 Form 13F File Number: 028-15704 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: COLBY BARNETT Title: CONTROLLER Phone: 205-263-4733 Signature, Place, and Date of Signing: /s/ COLBY BARNETT BIRMINGHAM, ALABAMA 07-13-2021 [Signature] [City, State] [Date] Report Type (Check only one.): ☒ 13F HOLDINGS REPORT. -
The Sure Dividend Newsletter, Where It Ranked 9Th in Our Top 10
Sure Dividend LONG-TERM INVESTING IN HIGH-QUALITY DIVIDEND SECURITIES April 2021 Edition By Ben Reynolds, Bob Ciura, Josh Arnold, & Eli Inkrot Edited by Brad Beams Published on April 4th, 2021 2 Table of Contents Opening Thoughts - Today’s Market Is Overvalued & Could Correct- ................................. 3 Sell Recommendations .................................................................................................................. 4 Kohl’s Corporation (KSS) .......................................................................................................... 4 UMB Financial Corporation (UMBF) ........................................................................................ 4 The Sure Dividend Top 10 – April 2021 ..................................................................................... 5 Analysis of Top 10 Securities ....................................................................................................... 6 L3Harris Technologies Inc. (LHX) ............................................................................................ 6 Northrop Grumman Corp. (NOC) .............................................................................................. 9 Enterprise Bancorp Inc. (EBTC) .............................................................................................. 12 AbbVie Inc. (ABBV) ................................................................................................................ 15 Bristol-Myers Squibb Co. (BMY) ........................................................................................... -
Ariel Focused Value Composite Quarter Ended June 30, 2021
Ariel Focused Value Composite Quarter Ended June 30, 2021 Quarter Ended June 30, 2021 Markets worldwide continued their upward trajectory in current levels, given favorable business trends, continued the second quarter. Record levels of fiscal support, pent-up positive momentum on strategic initiatives and active consumer demand and rising COVID-19 vaccination rates expense/capital management programs. continue to fuel the global economic recovery. As the re- In addition, Global leader in enterprise software, Oracle opening progresses, implications for inflation and the Corporation (ORCL) outperformed in the period and delivered a timing of rate hikes has ignited investor anxiety. While we robust earnings beat. ORCL currently holds the top two market expect volatility to elevate, we view such jitters as short- share spots for cloud ERP businesses and management is term noise within the context of our long-term investment optimistic about the Oracle Database business, whose latest horizon. Against this backdrop, the Ariel Focused Value version has been upgraded to include a new ultra-high- Composite delivered +3.18% gross of fees (+3.02% net performance parallel processing query engine called HeatWave. of fees) in the quarter, underperforming both the Russell As a result, industry analysts are seeing a 10x increase in 1000 Value Index and S&P 500 returns of +5.21% and Oracle Cloud Infrastructure customer inquiries. In our view, this +8.55%, respectively. bodes well for the future of ORCL’s cloud business. Several stocks in the portfolio had strong returns in the Alternatively, several positions weighed on performance. quarter. Oil and natural gas explorer APA Corporation Leading provider of specialty industrial services, Team, Inc. -
Usef-I Q2 2021
Units Cost Market Value U.S. EQUITY FUND-I U.S. Equities 88.35% Domestic Common Stocks 10X GENOMICS INC 5,585 868,056 1,093,655 1ST SOURCE CORP 249 9,322 11,569 2U INC 301 10,632 12,543 3D SYSTEMS CORP 128 1,079 5,116 3M CO 11,516 2,040,779 2,287,423 A O SMITH CORP 6,897 407,294 496,998 AARON'S CO INC/THE 472 8,022 15,099 ABBOTT LABORATORIES 24,799 2,007,619 2,874,948 ABBVIE INC 17,604 1,588,697 1,982,915 ABERCROMBIE & FITCH CO 1,021 19,690 47,405 ABIOMED INC 9,158 2,800,138 2,858,303 ABM INDUSTRIES INC 1,126 40,076 49,938 ACACIA RESEARCH CORP 1,223 7,498 8,267 ACADEMY SPORTS & OUTDOORS INC 1,036 35,982 42,725 ACADIA HEALTHCARE CO INC 2,181 67,154 136,858 ACADIA REALTY TRUST 1,390 24,572 30,524 ACCO BRANDS CORP 1,709 11,329 14,749 ACI WORLDWIDE INC 6,138 169,838 227,965 ACTIVISION BLIZZARD INC 13,175 839,968 1,257,422 ACUITY BRANDS INC 1,404 132,535 262,590 ACUSHNET HOLDINGS CORP 466 15,677 23,020 ADAPTHEALTH CORP 1,320 39,475 36,181 ADAPTIVE BIOTECHNOLOGIES CORP 18,687 644,897 763,551 ADDUS HOMECARE CORP 148 13,034 12,912 ADOBE INC 5,047 1,447,216 2,955,725 ADT INC 3,049 22,268 32,899 ADTALEM GLOBAL EDUCATION INC 846 31,161 30,151 ADTRAN INC 892 10,257 18,420 ADVANCE AUTO PARTS INC 216 34,544 44,310 ADVANCED DRAINAGE SYSTEMS INC 12,295 298,154 1,433,228 ADVANCED MICRO DEVICES INC 14,280 895,664 1,341,320 ADVANSIX INC 674 15,459 20,126 ADVANTAGE SOLUTIONS INC 1,279 14,497 13,800 ADVERUM BIOTECHNOLOGIES INC 1,840 7,030 6,440 AECOM 5,145 227,453 325,781 AEGLEA BIOTHERAPEUTICS INC 287 1,770 1,998 AEMETIS INC 498 6,023 5,563 AERSALE CORP -
QS US Small Capitalization Equity
Hand Composite Employee Benefit Trust QS U.S. Small Capitalization Equity CIF Independent Auditor's Report and Financial Statements December 31, 2019 Hand Composite Employee Benefit Trust December 31, 2019 Contents Independent Auditor's Report ............................................................................................ 1 Basic Financial Statements Statement of Assets and Liabilities - Selected Fund ........................................................................ 3 Schedule of Investments QS U.S. Small Capitalization Equity CIF ................................................................................. 4 Statement of Operations - Selected Fund ....................................................................................... 16 Statement of Changes in Net Assets - Selected Fund .................................................................... 17 Notes to Financial Statements ........................................................................................................ 18 Supplemental Information Schedule of Investment Purchases and Sales - Selected Fund ....................................................... 24 Independent Auditor's Report Board of Directors Hand Composite Employee Benefit Trust Houston, Texas We have audited the accompanying financial statements of the selected fund, QS U.S. Small Capitalization Equity CIF, included in the Hand Composite Employee Benefit Trust ("Trust" or "Fund"), which comprise the statement of assets and liabilities, including the schedule of investments,